Daiwa Securities Group
CCCC icon

Daiwa Securities Group’s C4 Therapeutics CCCC Stock Holding History

Daiwa Securities Group’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-142
Closed – – 1334
2023
Q3 		$0 Hold
142
– – ﹤0.01% 1296
2023
Q2 		$0 Hold
142
– – ﹤0.01% 1328
2023
Q1 		$0 Hold
142
– – ﹤0.01% 1304
2022
Q4 		$1K Hold
142
– – ﹤0.01% 1260
2022
Q3 		$1K Hold
142
– – ﹤0.01% 1279
2022
Q2 		$1K Hold
142
– – ﹤0.01% 1280
2022
Q1 		$3K Hold
142
– – ﹤0.01% 1212
2021
Q4 		$5K Buy
+142
New +$5.62K ﹤0.01% 1193

Other funds holding CCCC

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Daiwa Securities Group's CCCC Position: Q4 2023 in Review

Daiwa Securities Group sold out of C4 Therapeutics (CCCC) in Q4 2023, closing a stake of 142 shares.

Daiwa Securities Group first reported a position in CCCC in Q4 2021 and held it in 8 quarters. The position peaked at $5K in Q4 2021. 92 funds tracked by Wall St. Rank hold CCCC as of Q4 2023.

  • Daiwa Securities Group reported no remaining C4 Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Daiwa Securities Group sold 142 C4 Therapeutics shares in Q4 2023.
  • Daiwa Securities Group first reported a position in C4 Therapeutics in Q4 2021 and held it in 8 quarters.
  • Daiwa Securities Group's C4 Therapeutics position peaked at $5K in Q4 2021.
  • 92 funds tracked by Wall St. Rank held C4 Therapeutics as of Q4 2023.

Based on Daiwa Securities Group's 13F filing for Q4 2023, filed 31 Jan 2024.